Optometrists in Melrose, MA Accepting Medicare
7 Optometrists found. Showing 1 - 7
 Suburban Eye Associates Optometrist Medicare: Medicare Enrolled Practice Location: 511 Main St, Melrose, MA 02176 Phone: 781-662-9229 Fax: 781-662-1568 |
 Dr. Harland Winslow Robinson Iii, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 490 Main Street, Melrose, MA 02176 Phone: 781-665-0897 Fax: 781-665-8828 |
Dr. Herbert L Schurgin, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 511 Main St, Melrose, MA 02176 Phone: 781-662-9229 Fax: 781-662-1568 |
Melrose Family Opticians Llc Optometrist Medicare: Medicare Enrolled Practice Location: 490 Main St, Melrose, MA 02176 Phone: 781-665-0897 Fax: 781-665-8828 |
Dr. Frederick Thomas Leung, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 27 Pebble Rd, Melrose, MA 02176 Phone: 781-620-0305 |
 Kim Ciampa-maggio, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 490 Main St, Melrose, MA 02176 Phone: 781-665-0897 Fax: 781-665-8828 |
Dr. Harland Robinson Iii Optometrist Medicare: Not Enrolled in Medicare Practice Location: 490 Main St, Melrose, MA 02176 Phone: 781-665-0897 Fax: 781-665-8828 |
News Archive
TASTE trial questions the usefulness of thrombus aspiration after heart attack
Aspiration of the blood clot or "thrombus" that causes a heart attack before re-opening a patient's artery with a balloon catheter does not improve survival compared to performing balloon dilation and stenting alone according to the results of the Thrombus Aspiration in ST- Elevation myocardial infarction in Scandinavia (TASTE) trial.
Scientists working to control zeolite's properties to improve hemodialysis
Scientists of Tomsk State University are working on changing physicochemical properties of zeolites using thermal and mechanical treatment.
Some people with HIV/AIDS in Zambia are abandoning their antiretroviral drug regimens for ineffective cures
Some people living with HIV/AIDS in Zambia are abandoning their antiretroviral drug regimens for ineffective drugs that in recent weeks have been promoted in the media as cures for the disease, the Network of Zambian People Living with HIV and AIDS said on Monday, AFP/Independent Online reports.
Enrollment completes for Inovio Biomedical's dose escalation phase I trial of cervical cancer vaccine
Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that the company has completed enrollment of all subjects for its therapeutic cervical cancer vaccine (VGX-3100) phase I trial. VGX-3100 is a DNA vaccine targeting the E6 and E7 proteins of human papillomavirus (HPV) types 16 and 18, and is delivered via in vivo electroporation.
Bionovo's Menerba Phase 2 trial data to be presented at Annual World Congress on Menopause
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced it will be presenting data from the Phase 2 clinical trial of their lead drug candidate for postmenopausal symptoms, Menerba, to the international community at the 13th Annual World Congress on Menopause in Rome, Italy on June 11, 2011.
› Verified 9 days ago
Physical Therapists
Speech-Language Pathologists
Occupational Therapists
Optometrists
Chiropractors
Podiatrists